About
The immune system defends us, and sometimes it turns on us. I want to know whether that balance can be tipped on purpose.
The question took me from Miami to Chicago to New York, by way of protein engineering, computational biology, and a lot of mouse work.
I'm a postdoctoral researcher at NYU, working with Jeffrey Hubbell on proteins that use efferocytic pathways to induce tolerance to one antigen at a time, in autoimmune disease and in transplantation.
I write my own computational tools as I go, usually to make an analysis reproducible or to take a tedious step out of the week.
Education
Ph.D., Molecular Engineering
University of Chicago, Pritzker School of Molecular Engineering
Advisor: Jeffrey A. Hubbell
Dissertation: Recombinant Fusions of Antigen with Mediators of Efferocytosis Modulate Antigen-Specific Immune Responses
B.S., Biomedical Engineering, Summa Cum Laude
University of Miami
High School
Illinois Mathematics & Science Academy
Technical Expertise
Wet Lab
Computational
I lead the single-cell multiome and spatial-transcriptomics analysis on a Colton Center for Autoimmunity grant.
AI-Augmented Workflow
I use LLM agents daily, mostly to build the tooling my experiments need and to manage observations and data analysis. I work with foundation models developed to predict small molecule binding to proteins, leveraging this to design novel research projects in immunomodulation.
Research Focus
My work rests on one hypothesis: that efferocytosis, the process by which phagocytes clear apoptotic cells, can be used to induce tolerance to a chosen antigen.
If a protein can engage those pathways while carrying the right antigen, autoimmune disease and transplant rejection might be treated without suppressing the whole immune system, as current therapies do.